Literature DB >> 28919076

Mitochondrial Priming by CD28.

Ramon I Klein Geltink1, David O'Sullivan1, Mauro Corrado1, Anna Bremser2, Michael D Buck1, Joerg M Buescher1, Elke Firat3, Xuekai Zhu4, Gabriele Niedermann5, George Caputa1, Beth Kelly1, Ursula Warthorst6, Anne Rensing-Ehl6, Ryan L Kyle1, Lana Vandersarren7, Jonathan D Curtis1, Annette E Patterson1, Simon Lawless1, Katarzyna Grzes1, Jing Qiu1, David E Sanin1, Oliver Kretz8, Tobias B Huber9, Sophie Janssens7, Bart N Lambrecht7, Angelika S Rambold2, Edward J Pearce10, Erika L Pearce11.   

Abstract

T cell receptor (TCR) signaling without CD28 can elicit primary effector T cells, but memory T cells generated during this process are anergic, failing to respond to secondary antigen exposure. We show that, upon T cell activation, CD28 transiently promotes expression of carnitine palmitoyltransferase 1a (Cpt1a), an enzyme that facilitates mitochondrial fatty acid oxidation (FAO), before the first cell division, coinciding with mitochondrial elongation and enhanced spare respiratory capacity (SRC). microRNA-33 (miR33), a target of thioredoxin-interacting protein (TXNIP), attenuates Cpt1a expression in the absence of CD28, resulting in cells that thereafter are metabolically compromised during reactivation or periods of increased bioenergetic demand. Early CD28-dependent mitochondrial engagement is needed for T cells to remodel cristae, develop SRC, and rapidly produce cytokines upon restimulation-cardinal features of protective memory T cells. Our data show that initial CD28 signals during T cell activation prime mitochondria with latent metabolic capacity that is essential for future T cell responses.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CD28; CD8 T cells; Cpt1a; adoptive cellular immunotherapy; costimulation; memory T cells; mir33; mitochondrial cristae remodeling; mitochondrial morphology; spare respiratory capacity

Mesh:

Substances:

Year:  2017        PMID: 28919076      PMCID: PMC5637396          DOI: 10.1016/j.cell.2017.08.018

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  44 in total

1.  Mitochondrial Biogenesis and Proteome Remodeling Promote One-Carbon Metabolism for T Cell Activation.

Authors:  Noga Ron-Harel; Daniel Santos; Jonathan M Ghergurovich; Peter T Sage; Anita Reddy; Scott B Lovitch; Noah Dephoure; F Kyle Satterstrom; Michal Sheffer; Jessica B Spinelli; Steven Gygi; Joshua D Rabinowitz; Arlene H Sharpe; Marcia C Haigis
Journal:  Cell Metab       Date:  2016-07-12       Impact factor: 27.287

2.  Synergy between the T3/antigen receptor complex and Tp44 in the activation of human T cells.

Authors:  A Weiss; B Manger; J Imboden
Journal:  J Immunol       Date:  1986-08-01       Impact factor: 5.422

3.  Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis.

Authors:  Katey J Rayner; Frederick J Sheedy; Christine C Esau; Farah N Hussain; Ryan E Temel; Saj Parathath; Janine M van Gils; Alistair J Rayner; Aaron N Chang; Yajaira Suarez; Carlos Fernandez-Hernando; Edward A Fisher; Kathryn J Moore
Journal:  J Clin Invest       Date:  2011-06-06       Impact factor: 14.808

Review 4.  Targeting T cell metabolism for therapy.

Authors:  David O'Sullivan; Erika L Pearce
Journal:  Trends Immunol       Date:  2015-01-15       Impact factor: 16.687

5.  Memory CD8+ T cells require CD28 costimulation.

Authors:  Annie B Borowski; Alina C Boesteanu; Yvonne M Mueller; Caterina Carafides; David J Topham; John D Altman; Stephen R Jennings; Peter D Katsikis
Journal:  J Immunol       Date:  2007-11-15       Impact factor: 5.422

6.  TXNIP regulates myocardial fatty acid oxidation via miR-33a signaling.

Authors:  Junqin Chen; Martin E Young; John C Chatham; David K Crossman; Louis J Dell'Italia; Anath Shalev
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-05-03       Impact factor: 4.733

7.  4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors.

Authors:  Adrienne H Long; Waleed M Haso; Jack F Shern; Kelsey M Wanhainen; Meera Murgai; Maria Ingaramo; Jillian P Smith; Alec J Walker; M Eric Kohler; Vikas R Venkateshwara; Rosandra N Kaplan; George H Patterson; Terry J Fry; Rimas J Orentas; Crystal L Mackall
Journal:  Nat Med       Date:  2015-05-04       Impact factor: 53.440

8.  Mitochondrial Membrane Potential Identifies Cells with Enhanced Stemness for Cellular Therapy.

Authors:  Madhusudhanan Sukumar; Jie Liu; Gautam U Mehta; Shashank J Patel; Rahul Roychoudhuri; Joseph G Crompton; Christopher A Klebanoff; Yun Ji; Peng Li; Zhiya Yu; Greg D Whitehill; David Clever; Robert L Eil; Douglas C Palmer; Suman Mitra; Mahadev Rao; Keyvan Keyvanfar; David S Schrump; Ena Wang; Francesco M Marincola; Luca Gattinoni; Warren J Leonard; Pawel Muranski; Toren Finkel; Nicholas P Restifo
Journal:  Cell Metab       Date:  2015-12-08       Impact factor: 27.287

9.  Regulation of mitochondrial morphology and function by stearoylation of TFR1.

Authors:  Deniz Senyilmaz; Sam Virtue; Xiaojun Xu; Chong Yew Tan; Julian L Griffin; Aubry K Miller; Antonio Vidal-Puig; Aurelio A Teleman
Journal:  Nature       Date:  2015-07-27       Impact factor: 49.962

10.  CD28-inducible transcription factor DEC1 is required for efficient autoreactive CD4+ T cell response.

Authors:  Marc Martínez-Llordella; Jonathan H Esensten; Samantha L Bailey-Bucktrout; Robert H Lipsky; Ann Marini; Jun Chen; Mohamed Mughal; Mark P Mattson; Dennis D Taub; Jeffrey A Bluestone
Journal:  J Exp Med       Date:  2013-07-22       Impact factor: 14.307

View more
  97 in total

1.  Lipid Metabolism in Tumor-Infiltrating T Cells.

Authors:  Shangwen He; Ting Cai; Juanjuan Yuan; Xiaojun Zheng; Wei Yang
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  Targeting Metabolism to Improve the Tumor Microenvironment for Cancer Immunotherapy.

Authors:  Jackie E Bader; Kelsey Voss; Jeffrey C Rathmell
Journal:  Mol Cell       Date:  2020-06-18       Impact factor: 17.970

3.  Immunometabolism: From basic mechanisms to translation.

Authors:  Liza Makowski; Mehdi Chaib; Jeffrey C Rathmell
Journal:  Immunol Rev       Date:  2020-05       Impact factor: 12.988

4.  Imaging of Activated T Cells as an Early Predictor of Immune Response to Anti-PD-1 Therapy.

Authors:  Jelena Levi; Tina Lam; Samuel R Goth; Shahriar Yaghoubi; Jennifer Bates; Gang Ren; Salma Jivan; Tony L Huynh; Joseph E Blecha; Roli Khattri; Karl F Schmidt; Dominique Jennings; Henry VanBrocklin
Journal:  Cancer Res       Date:  2019-05-07       Impact factor: 12.701

5.  Mitochondrial Membrane Potential Regulates Nuclear Gene Expression in Macrophages Exposed to Prostaglandin E2.

Authors:  David E Sanin; Mai Matsushita; Ramon I Klein Geltink; Katarzyna M Grzes; Nikki van Teijlingen Bakker; Mauro Corrado; Agnieszka M Kabat; Michael D Buck; Jing Qiu; Simon J Lawless; Alanna M Cameron; Matteo Villa; Francesc Baixauli; Annette E Patterson; Fabian Hässler; Jonathan D Curtis; Christina M O'Neill; David O'Sullivan; Duojiao Wu; Gerhard Mittler; Stanley Ching-Cheng Huang; Erika L Pearce; Edward J Pearce
Journal:  Immunity       Date:  2018-12-18       Impact factor: 31.745

Review 6.  mTOR and other effector kinase signals that impact T cell function and activity.

Authors:  Darienne R Myers; Benjamin Wheeler; Jeroen P Roose
Journal:  Immunol Rev       Date:  2019-09       Impact factor: 12.988

7.  Inflammescent CX3CR1+CD57+CD8+ T cells are generated and expanded by IL-15.

Authors:  Stephen R Morris; Bonnie Chen; Joseph C Mudd; Soumya Panigrahi; Carey L Shive; Scott F Sieg; Cheryl M Cameron; David A Zidar; Nicholas T Funderburg; Souheil-Antoine Younes; Benigno Rodriguez; Sara Gianella; Michael M Lederman; Michael L Freeman
Journal:  JCI Insight       Date:  2020-06-04

8.  Cutting Edge: Glycolytic Metabolism and Mitochondrial Metabolism Are Uncoupled in Antigen-Activated CD8+ Recent Thymic Emigrants.

Authors:  Cody A Cunningham; Suzanne Hoppins; Pamela J Fink
Journal:  J Immunol       Date:  2018-08-01       Impact factor: 5.422

9.  Phosphoproteomic analysis of chimeric antigen receptor signaling reveals kinetic and quantitative differences that affect cell function.

Authors:  Alexander I Salter; Richard G Ivey; Jacob J Kennedy; Valentin Voillet; Anusha Rajan; Eva J Alderman; Uliana J Voytovich; Chenwei Lin; Daniel Sommermeyer; Lingfeng Liu; Jeffrey R Whiteaker; Raphael Gottardo; Amanda G Paulovich; Stanley R Riddell
Journal:  Sci Signal       Date:  2018-08-21       Impact factor: 8.192

10.  Metabolic conditioning of CD8+ effector T cells for adoptive cell therapy.

Authors:  Ramon I Klein Geltink; Joy Edwards-Hicks; Petya Apostolova; David O'Sullivan; David E Sanin; Annette E Patterson; Daniel J Puleston; Nina A M Ligthart; Joerg M Buescher; Katarzyna M Grzes; Agnieszka M Kabat; Michal Stanczak; Jonathan D Curtis; Fabian Hässler; Franziska M Uhl; Mario Fabri; Robert Zeiser; Edward J Pearce; Erika L Pearce
Journal:  Nat Metab       Date:  2020-08-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.